SGEM#236: TXA – Not for Brain Bleeds. Sprigg et al. Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage (TICH-2): an international randomised, placebo-controlled, phase 3 superiority trial. Lancet. 2018
SGEM Paper in a Pic #236
About The Author
Related Posts
Recent Tweets
-
RT @EddyLang1: Leaving for the @CAEPConference and Yeehaw! I am stoked. @Halifaxconnie @TheSGEM @EMCases @UCalgaryEM @Andrew_McRae_EM @WeA…
-
@lucasojesilva12 @mfbellolio @CabreraERDR @painfreeED Small study (n=32) and unblinded. Skeptical in a properly poâ€twitter.com/i/web/status/1…kb
-
@drjohnm @jeremyfaust @EMNerd_ @emlitofnote The authors' reported COI in this SRMA published in the Lancet on tPA fâ€twitter.com/i/web/status/1…1l
-
@drjohnm @jeremyfaust @EMNerd_ @emlitofnote I will download and put my skeptical eye upon the article. As Dr. Ricâ€twitter.com/i/web/status/1…nm
-
@drjohnm @RogueRad @jeremyfaust Unblinded, self-reported, industry sponsored, negative primary out come with increaâ€twitter.com/i/web/status/1…1P
-
@RCEMLearning Here is some help from the SGEM. thesgem.com/2016/10/sgem16…
Listen to Us
Upcoming Conferences
May 2019 |
||||||
|---|---|---|---|---|---|---|
| Mon | Tue | Wed | Thu | Fri | Sat | Sun |
|
1
|
2
|
3
|
4
|
5
|
||
|
6
|
7
|
8
|
9
|
10
|
11
|
12
|
|
13
|
14
|
15
|
16
|
17
|
18
|
19
|
|
20
|
21
|
22
|
23
|
24
|
25
|
26
|
|
27
|
28
|
29
|
30
|
31
|
||